Drugs / Viral Vector COVID-19 vaccine (AstraZeneca)
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05465902 Comparator | Jul 2023 → Nov 2024 | COVID-19 | WestVac Biopharma Co., Ltd. | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Viral Vector COVID-19 vaccine (AstraZeneca) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05465902 ↗ |
| Route | Intramuscular | “1dose, Intramuscular Injection” NCT05465902 ↗ |